761results about How to "Quick cure" patented technology

Coating compounds curable by means of high-energy radiation, comprising as binderA) at least one (meth)acrylic copolymer containing olefinic double bonds capable of free-radical polymerization and hydroxyl groups with a C=C equivalent weight from 100 to 10,000 and an OH-value from 20 to 250 mg KOH / g, which is prepared from monomers comprising:A1) at least one olefinically unsaturated, epoxy-functional monomer capable of free-radical polymerization,A2) at least one olefinically unsaturated, carboxy-functional monomer capable of free-radical polymerization andA3) at least one further olefinically unsaturated monomer capable of free-radical polymerization which is different from A1) and A2), andB) at least one component with free isocyanate groups and process for multilayer coating using the coating compounds.

Medical devices, methods and systems for treating tissue are provided. An exemplary system comprises a fluid from a fluid from a fluid source at a fluid flow rate, a surgical device which provides power and the fluid to the tissue and a control mechanism which changes a fluid flow rate provided from the surgical device and changes a power level provided from the surgical device. The fluid flow rate changes between at least two-zero flow rates and the power level changes between at least two non-zero levels. An exemplary method comprises providing a fluid from a fluid source at a fluid flow rate, providing a surgical device which provides power and the fluid to the tissue, and changing the fluid flow rate of fluid provided from the surgical device with a change in power level provided from the surgical device.

Medical devices, methods and systems for treating tissue are provided. An exemplary system comprises a fluid from a fluid source, a surgical device which provides energy and the fluid to the tissue and a control mechanism which changes a flow rate of fluid provided from the surgical device and changes a rate of energy provided from the surgical device. The fluid flow rate changes between at least two non-zero flow rates and the energy rate changes between at least two non-zero energy rates. An exemplary method comprises providing a fluid from a fluid source, providing a surgical device which provides energy and the fluid to the tissue, and changing a flow rate of fluid provided from the surgical device with a change in a rate of energy provided from the surgical device. Exemplary devices comprise a tip portion configured to provide energy and a fluid to a tissue.

A system for optimizing response time to events or representations thereof waiting in a queue has a first server having access to the queue; a software application running on the first server; and a second server accessible from the first server, the second server containing rules governing the optimization. In a preferred embodiment, the software application at least periodically accesses the queue and parses certain ones of events or tokens in the queue and compares the parsed results against rules accessed from the second server in order to determine a measure of disposal time for each parsed event wherein if the determined measure is sufficiently low for one or more of the parsed events, those one or more events are modified to a reflect a higher priority state than originally assigned enabling faster treatment of those events resulting in relief from those events to the queue system load.

The invention concerns an expandable intersomatic cage (1) intended to be implanted between a first and second vertebral bodies of a patient, comprising:a cage body (2), comprising a bearing surface (6A) intended to be positioned so as to bear against the first vertebral body (4),an expansion cap (3) mounted on the cage body (2) so as to be able to pivot relative to the bearing surface (6A), said expansion cap (3) comprising an element (3A) for bearing against the second vertebral body (5),a means (16) for controlling the inclination of the expansion cap (3).said cage (1) being characterized in that the body (2) comprises at least one fastening orifice (41) forming an oblique well (42) capable of receiving and guiding from the outside of said cage (1) a means for fastening the cage (1) to the first and / or to the second vertebral body.Surgical implants.

The present invention is directed to a novel progression of topical and oral administration or use of lactoferrin or lactoferrin and other biological ingredients to prevent and treat dermatological conditions or disorders in humans. More specifically, the present invention is directed to the administration of lactoferrin in a topical material such as an ointment or cream to the skin of humans and also including a oral administration, together the topical and oral administration has a synergetic effect in the treatment of the skin. The progression of medicaments of the present invention are: 1) lactoferrin; 2) lactoferrin and conjugated linoleic acids; 3) lactoferrin, a plant or animal derived lipid and oblepicha; 4) lactoferrin, a plant or animal derived lipid, oblepicha, and an omega fatty acid; and 5) lactoferrin, a plant or animal derived lipid, oblepicha, an omega fatty acid and a whey protein.

A magnetic stimulation device and methods use a plurality of magnetic field generating devices, allowing for faster treatment of a patient and for treatment of large areas of the body. The shape of the generated magnetic field may be adjusted by an operator. The magnetic stimulation device is able to provide a plurality of various treatments at the same time.

The invention provides methods for treating or preventing microbial (eg, bacterial) infections and means for performing these methods. In particular, treatment of infections requiring rapid and durable therapy is made possible, such as for treating acute conditions such as septicemia, sepsis, SIRS or septic shock. The invention is particularly useful, for example, for treatment of microbes such as for environmental, food and beverage use. The invention relates inter alia to methods of controlling microbiologically influenced corrosion (MIC) or biofouling of a substrate or fluid in an industrial or domestic system. The invention also useful for the treatment of pathogenic bacterial infections in subjects receiving a treatment for a disease or condition, such as a transplant or a treatment for cancer, a viral infection or an autoimmune disease.

The invention discloses an in-vivo wireless communication device based on a vascular stent and a wireless communication system. The in-vivo wireless communication device comprises the vascular stent and a trigger circuit mounted on the vascular stent, the trigger circuit is used for acquiring health condition data related to vascular diseases and / or providing in-vivo therapy related to the vascular diseases, an output of the trigger circuit is fed to the vascular stent, the vascular stent serves as an antenna to transmit wireless signals outwards, and the vascular stent further serves as the antenna to receive wireless signals in vitro and transmit the wireless signals to the trigger circuit. A special antenna structure does not need to be arranged in a blood vessel, the in-vivo wireless communication device is small in size, and the blood vessel can be monitored and treated in real time at low cost.

The invention discloses gRNA for knockout of a wild type T cell TCR [beta] strand and a method. The sequence of the gRNA is as shown in SEQ ID NO: 1, by utilizing a CRISPR / Cas9 technology, the gRNA and CRISPR / Cas9 jointly infect a T cell, the wild type T cell TCR [beta] strand is knocked out, and the T cell lacking the wild type TCR [beta] strand is constructed and used for CAR-T or TCR-T cellular immunotherapy. According to the gRNA for knockout of the wild type T cell TCR [beta] strand and the method, the knockout efficiency is high, the preparation method is relatively simple and easy, and T cells lacking wild type TCR [beta] strands can be provided for clinic rapidly and efficiently.

Pharmaceutical compositions containing dihydroergotamine (DHE) and methods in which DHE is administered to patients for treatment of migraine without side effects or adverse effects are disclosed. Methods for rapid treatment of migraine with DHE are disclosed comprising: dampening the peak plasma concentration (Cmax) and slightly delaying the peak such as to avoid activating the dopaminergic and adrenergic receptors, while achieving sufficient active binding to the serotonin receptors to provide relief from migraine symptoms within a timeframe that permits rapid resolution of migraine symptoms. Inhaler devices suitable for the methods are disclosed. Kits for practicing the methods of invention are disclosed.

In methods for treating a patient, a time varying magnetic field is applied to a patient's body and causes a muscle contraction. The time-varying magnetic field may be monophasic, biphasic, polyphasic and / or static. The method may reduce adipose tissue, improve metabolism, blood and / or lymph circulation. The method may use combinations of treatments to enhance the visual appearance of the patient.

Disclosed herein are devices and methods for guiding a surgical instrument for resecting a portion of a humerus of a patient. The surgical instrument is a patient-specific cutting guide having a base portion having a contact surface shaped to substantially match an outer surface of a neck portion of the humerus. The guide includes at least one proximal stabilization member extending medially from the base portion and having a contact surface shaped to substantially match an outer surface of a head portion of the humerus. The guide further includes at least one distal stabilization member extending distally from the base portion and having a contact surface shaped to substantially match an outer surface of a shaft portion of the humerus. The base portion includes a guide slot for guiding the surgical instrument.

Methods for treating malaria are provided, the treatment comprising the step of removing malaria-infected red blood cells from the patient s blood. Blood is drawn from the patient s circulatory system and circulated through a blood purification device that selectively eliminates the infected red blood cells from all other blood s components and replaces the cleansed blood back into the patient s circulatory system. A blood purification device, which is useful to perform the therapeutic methods of the invention, is also provided. The device leverages the magnetic properties of the hemozoin contained within the infected red blood cells and comprises one or more separation chambers (4) though which blood flows through a high-gradient magnetic field generated by an array of wires (5) separated from the chambers and not in contact with the patient blood. The magnetic field gradient acting on the cells magnetic properties displaces the infected and non-infected red blood cells on different layers of the blood flow across the chamber height. The blood flow is split into separated streams and blood streams containing infected cells are filtrated thereby trapping infected cells. Blood containing non-infected red blood cells is circulated back to the patient. The device application is not limited to the treatment of malaria and includes other blood related diseases that affect the magnetic properties of a patient's red blood cells.